We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

4 hedge funds and large institutions have $7.5M invested in Plus Therapeutics in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 5 → 4 (-1)

33% less capital invested

Capital invested by funds: $11.1M → $7.5M (-$3.62M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$76K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GCM
Goldman Capital Management
New York
-$1.36M
2
Renaissance Technologies
Renaissance Technologies
New York
-$321K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$45K
4
GS
Gagnon Securities
New York
-$38K
5
AC
Amici Capital
New York
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$9K – – –
AP
52
Atwood & Palmer
Missouri
$8K – – –
ProShare Advisors
53
ProShare Advisors
Maryland
$8K – – –
LPL Financial
54
LPL Financial
California
$7K – – –
Ameriprise
55
Ameriprise
Minnesota
$6K – – –
Bank of America
56
Bank of America
North Carolina
$6K – – –
Creative Planning
57
Creative Planning
Kansas
$6K – – –
M&T Bank
58
M&T Bank
New York
$6K – – –
Principal Financial Group
59
Principal Financial Group
Iowa
$6K – – –
AllianceBernstein
60
AllianceBernstein
Tennessee
$5K – – –
EWA
61
Exencial Wealth Advisors
Oklahoma
$5K – – –
JG
62
Jefferies Group
New York
$5K – – –
Two Sigma Advisers
63
Two Sigma Advisers
New York
$5K – – –
Deutsche Bank
64
Deutsche Bank
Germany
$4K – – –
PNC Financial Services Group
65
PNC Financial Services Group
Pennsylvania
$2K – – –
SM
66
Sabby Management
Florida
$1.02K – – –
BlackRock
67
BlackRock
New York
$1K – – –
TDC
68
Thompson Davis & Co
Virginia
$1K – – –
WA
69
Waverly Advisors
Alabama
$1K – – –
NPC
70
National Planning Corporation
California
$986 – – –
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 – – –
AC
72
Amici Capital
New York
– -$27K – –
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
– -$3.74K – –
GS
74
Gagnon Securities
New York
– -$38K – –
LI
75
LMCG Investments
Massachusetts
– -$14K – –
1 2
3
4

PSTV Hedge Fund Activity: Q4 2014 in Review

4 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2014, worth a combined $7.5M — down 33% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PSTV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Goldman Capital Management, exiting entirely with an estimated $1.36M sold.

  • 4 institutional investors held Plus Therapeutics (PSTV) as of Q4 2014, down from 5 in Q3 2014.
  • Funds reported $7.5M of Plus Therapeutics stock for Q4 2014, down 33% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q4 2014 and 1 closed out, a net change of -1 holder.
  • The largest Plus Therapeutics seller in Q4 2014 was Goldman Capital Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q4 2014.